Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
Vanguard Capital Management LLC reported a 5.19% stake in Crinetics Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Capital Management LLC reported a 5.19% stake in Crinetics Pharmaceuticals, Inc., 5,440,646 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.19%
- Shares
- 5,440,646
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.19% | 5,440,646 |
Source
Related
- Crinetics Pharmaceuticals, Inc.
- Vanguard Capital Management LLC
- Crinetics Pharmaceuticals, Inc. shareholders
- Form 4 · Wierenga Wendell · Sep 1, 2026
- Form 4 · Vivaldi Coelho Rogerio · Sep 1, 2026
- Form 4 · Okey Stephanie · Sep 1, 2026
- Form 4 · Nichols Weston · Sep 1, 2026
- Form 4 · Fust Matthew K · Sep 1, 2026